Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.115
-0.005 (-4.17%)
Mar 9, 2026, 12:24 PM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 657.14K CAD in the quarter ending November 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to 2.78M, up 72.84% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.
Revenue (ttm)
2.78M
Revenue Growth
+72.84%
P/S Ratio
5.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.22M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Britannia Life Sciences | 157.68K |
| Innovotech | 4.46M |
| Pharmala Biotech Holdings | 754.64K |
| Glow Lifetech | 1.88M |
| Telescope Innovations | 6.28M |